ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST)
SEK 20.6
(-4.63%)
SEK 20.6
(-4.63%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.98 SEK | 43.31% |
| 2022 | -3.14 SEK | -130.88% |
| 2021 | -1.36 SEK | 18.07% |
| 2020 | -1.66 SEK | -61.17% |
| 2019 | -1.03 SEK | 9.65% |
| 2018 | -1.14 SEK | -40.74% |
| 2017 | -0.81 SEK | -8.0% |
| 2016 | -0.75 SEK | 35.34% |
| 2015 | -1.16 SEK | -3112.99% |
| 2014 | 0.04 SEK | -59.43% |
| 2013 | 0.09 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.25 SEK | 28.57% |
| 2024 Q2 | 0.05 SEK | 888.0% |
| 2023 Q2 | -0.63 SEK | 10.0% |
| 2023 Q4 | -0.35 SEK | 20.45% |
| 2023 FY | - SEK | 43.31% |
| 2023 Q3 | -0.44 SEK | 30.16% |
| 2023 Q1 | -0.70 SEK | 41.67% |
| 2022 Q3 | -0.77 SEK | -10.0% |
| 2022 FY | - SEK | -130.88% |
| 2022 Q4 | -1.20 SEK | -55.84% |
| 2022 Q2 | -0.70 SEK | -75.0% |
| 2022 Q1 | -0.40 SEK | 4.76% |
| 2021 Q3 | -0.30 SEK | 0.0% |
| 2021 Q1 | -0.37 SEK | 65.42% |
| 2021 Q2 | -0.30 SEK | 18.92% |
| 2021 FY | - SEK | 18.07% |
| 2021 Q4 | -0.42 SEK | -40.0% |
| 2020 Q2 | -0.24 SEK | 27.27% |
| 2020 Q1 | -0.33 SEK | 23.26% |
| 2020 Q3 | -0.26 SEK | -8.33% |
| 2020 FY | - SEK | -61.17% |
| 2020 Q4 | -1.07 SEK | -311.54% |
| 2019 Q4 | -0.43 SEK | -126.32% |
| 2019 Q1 | -0.29 SEK | 32.56% |
| 2019 FY | - SEK | 9.65% |
| 2019 Q3 | -0.19 SEK | 0.0% |
| 2019 Q2 | -0.19 SEK | 34.48% |
| 2018 Q1 | -0.26 SEK | 21.21% |
| 2018 FY | - SEK | -40.74% |
| 2018 Q3 | -0.32 SEK | -39.13% |
| 2018 Q2 | -0.23 SEK | 11.54% |
| 2018 Q4 | -0.43 SEK | -34.37% |
| 2017 Q1 | -0.11 SEK | 77.08% |
| 2017 Q3 | -0.27 SEK | -12.5% |
| 2017 Q4 | -0.33 SEK | -22.22% |
| 2017 FY | - SEK | -8.0% |
| 2017 Q2 | -0.24 SEK | -118.18% |
| 2016 Q4 | -0.48 SEK | -77.78% |
| 2016 Q2 | -0.41 SEK | 65.25% |
| 2016 FY | - SEK | 35.34% |
| 2016 Q1 | -1.18 SEK | 0.0% |
| 2016 Q3 | -0.27 SEK | 34.15% |
| 2015 FY | - SEK | -3112.99% |
| 2014 FY | - SEK | -59.43% |
| 2013 FY | - SEK | 0.0% |